Arches is a technology company.
Arches has raised $450K across 1 funding round.
Arches has raised $450K in total across 1 funding round.
Arches has raised $450K in total across 1 funding round.
Arches's investors include Bain Capital.
Arches Technology (also known as Arches Health Technology) is a New York-based healthcare SaaS company founded in 2006 that builds Keystone, a HIPAA-compliant multi-channel content delivery platform for personalized patient education and engagement, primarily in oncology.[1][2][3] It serves life science companies, healthcare providers, and organizations by solving challenges like low health literacy, patient anxiety, poor treatment adherence, and inefficient clinical workflows through secure, scalable digital tools that integrate with EHR systems and deliver tailored content via preferred channels.[1][2][3] With under 25 employees and $5.2 million in revenue, Arches has shown growth through partnerships like the 2018 launch of My Care Compass with Kettering Health Network, demonstrating momentum in expanding oncology support services.[1]
Arches Technology was established in 2006, evolving from founder Daniella's extensive background in healthcare communications, patient relationship marketing, and direct-to-patient (DTP) strategies.[2][3] A serial entrepreneur, Daniella previously founded DKI, pioneering digital strategies for over 40 life science clients including Genentech and Novartis Oncology; co-founded Convergence Point Media in 2008 for healthcare media planning (exited 2014); and launched Entrada, a consulting firm (exited 2023), earning over 60 industry awards.[3] Her passion for data-driven patient engagement stemmed from recognizing gaps in traditional paper-based education, leading to Keystone's development as a flexible platform trusted by enterprises and emerging players.[1][2] Key milestones include appointing Patrick Flavin as President in 2018 to scale operations and launching patient navigation tools like My Care Compass.[1][3]
Arches rides the wave of digital patient engagement in oncology, where rising cancer prevalence, value-based care, and EHR adoption demand personalized, literacy-focused tools amid market forces like regulatory HIPAA pressures and post-pandemic telehealth growth.[2][3][6] Its timing aligns with healthcare's shift from mass communications to 1:1 relationships, leveraging big data and AI for better outcomes—evident in partnerships with networks like Kettering Health.[1] By enabling providers and pharma to enhance adherence and workflows, Arches influences the ecosystem, fostering innovation in health tech SaaS and supporting broader trends in patient-centered care.[1][2]
Arches is poised to expand Keystone's reach amid surging demand for AI-enhanced, compliant patient tools, potentially targeting more EHR integrations and synthetic data features seen in parallel VA initiatives (though distinct).[3][4] Trends like personalized medicine and analytics-driven care will propel growth, evolving its influence from niche oncology partner to broader healthcare engagement leader—building on two decades of trusted relationships to make patient journeys healthier and more efficient.[2][3]
Arches has raised $450K across 1 funding round. Most recently, it raised $450K Seed in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2020 | $450K Seed | Bain Capital |